ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Antibodies Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9P7711
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Intravenous Antibodies Market Insights Forecast to 2028
BUY CHAPTERS

Global Intravenous Antibodies Market Research Report 2025

Code: QYRE-Auto-9P7711
Report
July 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Biotest
Octapharma AG
Grifols S A
Kedrion S p A
Baxter
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Intravenous Antibodies Market Size

The global market for Intravenous Antibodies was valued at US$ 11550 million in the year 2024 and is projected to reach a revised size of US$ 17160 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Intravenous Antibodies Market

Intravenous Antibodies Market

Intravenous antibody is a plasma-derived human immunoglobulin product, which can improve the body"s immunity and inhibit the development of autoimmune diseases through intravenous administration. With the development of medical technology, IVIG will present the following development trends in clinical application:
Expansion of indications: At present, the indications of IVIG are mainly concentrated in areas such as immunodeficiency and autoimmune diseases. However, with the deepening of research, the application of IVIG in the fields of severe infection and neurological diseases is also constantly being explored. In the future, the scope of indications for IVIG may be further expanded to provide treatment options for more patients.
Improvement of preparation technology: At present, the preparation of IVIG mainly adopts plasma separation technology. With the development of biotechnology, emerging technologies such as genetic engineering and cell engineering may be applied to the preparation process of IVIG, thereby further improving the quality and safety of the product.
Personalized treatment: For different diseases and patient conditions, the dose and composition of IVIG may need to be adjusted individually. In the future, with the development of precision medical technology, personalized treatment of IVIG may be more widely used.
Combination therapy: In areas such as autoimmune diseases, IVIG is often used in combination with other drugs to improve efficacy. In the future, with the advancement of drug research and development, the combination therapy of IVIG and new drugs may become a research hotspot.
Safety concerns: Although the safety of IVIG has been widely recognized, as the scope of application expands and the patient population diversifies, the safety issues of IVIG still require continued attention. In the future, manufacturers and medical institutions will further strengthen the safety monitoring and research of IVIG.
In short, with the advancement of medical technology and the increase in clinical demand, intravenous antibodies will be used in more fields, and preparation technology, treatment strategies and other aspects will also be further improved and improved.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Antibodies.
The Intravenous Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous Antibodies Market Report

Report Metric Details
Report Name Intravenous Antibodies Market
Accounted market size in year US$ 11550 million
Forecasted market size in 2031 US$ 17160 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • IgG
  • IgA
  • IgM
  • IgE
  • IgD
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intravenous Antibodies Market growing?

Ans: The Intravenous Antibodies Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Intravenous Antibodies Market size in 2031?

Ans: The Intravenous Antibodies Market size in 2031 will be US$ 17160 million.

Who are the main players in the Intravenous Antibodies Market report?

Ans: The main players in the Intravenous Antibodies Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the Intravenous Antibodies Market report?

Ans: The Applications covered in the Intravenous Antibodies Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Intravenous Antibodies Market report?

Ans: The Types covered in the Intravenous Antibodies Market report are IgG, IgA, IgM, IgE, IgD

Recommended Reports

Intravenous Therapy Devices

IVD and Diagnostics

Antibody Markets

1 Intravenous Antibodies Market Overview
1.1 Product Definition
1.2 Intravenous Antibodies by Type
1.2.1 Global Intravenous Antibodies Market Value Comparison by Type (2024 VS 2031)
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Intravenous Antibodies by Application
1.3.1 Global Intravenous Antibodies Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Intravenous Antibodies Market Size Estimates and Forecasts
1.4.1 Global Intravenous Antibodies Revenue 2020-2031
1.4.2 Global Intravenous Antibodies Sales 2020-2031
1.4.3 Global Intravenous Antibodies Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Antibodies Market Competition by Manufacturers
2.1 Global Intravenous Antibodies Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Antibodies Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Antibodies Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Antibodies, Product Type & Application
2.7 Global Key Manufacturers of Intravenous Antibodies, Date of Enter into This Industry
2.8 Global Intravenous Antibodies Market Competitive Situation and Trends
2.8.1 Global Intravenous Antibodies Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Antibodies Players Market Share by Revenue
2.8.3 Global Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Antibodies Market Scenario by Region
3.1 Global Intravenous Antibodies Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Antibodies Sales by Region: 2020-2031
3.2.1 Global Intravenous Antibodies Sales by Region: 2020-2025
3.2.2 Global Intravenous Antibodies Sales by Region: 2026-2031
3.3 Global Intravenous Antibodies Revenue by Region: 2020-2031
3.3.1 Global Intravenous Antibodies Revenue by Region: 2020-2025
3.3.2 Global Intravenous Antibodies Revenue by Region: 2026-2031
3.4 North America Intravenous Antibodies Market Facts & Figures by Country
3.4.1 North America Intravenous Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Antibodies Sales by Country (2020-2031)
3.4.3 North America Intravenous Antibodies Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Antibodies Market Facts & Figures by Country
3.5.1 Europe Intravenous Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Antibodies Sales by Country (2020-2031)
3.5.3 Europe Intravenous Antibodies Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Antibodies Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Antibodies Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Antibodies Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Antibodies Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Antibodies Market Facts & Figures by Country
3.7.1 Latin America Intravenous Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Antibodies Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Antibodies Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Antibodies Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Antibodies Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Antibodies Sales by Type (2020-2031)
4.1.1 Global Intravenous Antibodies Sales by Type (2020-2025)
4.1.2 Global Intravenous Antibodies Sales by Type (2026-2031)
4.1.3 Global Intravenous Antibodies Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Antibodies Revenue by Type (2020-2031)
4.2.1 Global Intravenous Antibodies Revenue by Type (2020-2025)
4.2.2 Global Intravenous Antibodies Revenue by Type (2026-2031)
4.2.3 Global Intravenous Antibodies Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Antibodies Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Antibodies Sales by Application (2020-2031)
5.1.1 Global Intravenous Antibodies Sales by Application (2020-2025)
5.1.2 Global Intravenous Antibodies Sales by Application (2026-2031)
5.1.3 Global Intravenous Antibodies Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Antibodies Revenue by Application (2020-2031)
5.2.1 Global Intravenous Antibodies Revenue by Application (2020-2025)
5.2.2 Global Intravenous Antibodies Revenue by Application (2026-2031)
5.2.3 Global Intravenous Antibodies Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Antibodies Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Intravenous Antibodies Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Intravenous Antibodies Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Intravenous Antibodies Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Intravenous Antibodies Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biotest Intravenous Antibodies Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Intravenous Antibodies Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Bio Intravenous Antibodies Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CNBG Intravenous Antibodies Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai RAAS Intravenous Antibodies Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Intravenous Antibodies Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Company Information
6.11.2 LFB Group Description and Business Overview
6.11.3 LFB Group Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LFB Group Intravenous Antibodies Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPL Intravenous Antibodies Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Company Information
6.13.2 Sichuan Yuanda Shuyang Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sichuan Yuanda Shuyang Intravenous Antibodies Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Antibodies Industry Chain Analysis
7.2 Intravenous Antibodies Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Antibodies Production Mode & Process Analysis
7.4 Intravenous Antibodies Sales and Marketing
7.4.1 Intravenous Antibodies Sales Channels
7.4.2 Intravenous Antibodies Distributors
7.5 Intravenous Antibodies Customer Analysis
8 Intravenous Antibodies Market Dynamics
8.1 Intravenous Antibodies Industry Trends
8.2 Intravenous Antibodies Market Drivers
8.3 Intravenous Antibodies Market Challenges
8.4 Intravenous Antibodies Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Limited
Biotest
Octapharma AG
Grifols S A
Kedrion S p A
Baxter
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
List of Tables
 Table 1. Global Intravenous Antibodies Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravenous Antibodies Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravenous Antibodies Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravenous Antibodies Sales (K Bottles) of Key Manufacturers (2020-2025)
 Table 5. Global Intravenous Antibodies Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravenous Antibodies Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravenous Antibodies Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravenous Antibodies Average Price (US$/Bottle) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravenous Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravenous Antibodies, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravenous Antibodies, Product Type & Application
 Table 12. Global Key Manufacturers of Intravenous Antibodies, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Antibodies as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravenous Antibodies Sales by Region (2020-2025) & (K Bottles)
 Table 18. Global Intravenous Antibodies Sales Market Share by Region (2020-2025)
 Table 19. Global Intravenous Antibodies Sales by Region (2026-2031) & (K Bottles)
 Table 20. Global Intravenous Antibodies Sales Market Share by Region (2026-2031)
 Table 21. Global Intravenous Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravenous Antibodies Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravenous Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravenous Antibodies Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravenous Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravenous Antibodies Sales by Country (2020-2025) & (K Bottles)
 Table 27. North America Intravenous Antibodies Sales by Country (2026-2031) & (K Bottles)
 Table 28. North America Intravenous Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravenous Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravenous Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravenous Antibodies Sales by Country (2020-2025) & (K Bottles)
 Table 32. Europe Intravenous Antibodies Sales by Country (2026-2031) & (K Bottles)
 Table 33. Europe Intravenous Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravenous Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravenous Antibodies Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravenous Antibodies Sales by Region (2020-2025) & (K Bottles)
 Table 37. Asia Pacific Intravenous Antibodies Sales by Region (2026-2031) & (K Bottles)
 Table 38. Asia Pacific Intravenous Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravenous Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravenous Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravenous Antibodies Sales by Country (2020-2025) & (K Bottles)
 Table 42. Latin America Intravenous Antibodies Sales by Country (2026-2031) & (K Bottles)
 Table 43. Latin America Intravenous Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravenous Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravenous Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravenous Antibodies Sales by Country (2020-2025) & (K Bottles)
 Table 47. Middle East and Africa Intravenous Antibodies Sales by Country (2026-2031) & (K Bottles)
 Table 48. Middle East and Africa Intravenous Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravenous Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravenous Antibodies Sales (K Bottles) by Type (2020-2025)
 Table 51. Global Intravenous Antibodies Sales (K Bottles) by Type (2026-2031)
 Table 52. Global Intravenous Antibodies Sales Market Share by Type (2020-2025)
 Table 53. Global Intravenous Antibodies Sales Market Share by Type (2026-2031)
 Table 54. Global Intravenous Antibodies Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravenous Antibodies Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravenous Antibodies Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravenous Antibodies Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravenous Antibodies Price (US$/Bottle) by Type (2020-2025)
 Table 59. Global Intravenous Antibodies Price (US$/Bottle) by Type (2026-2031)
 Table 60. Global Intravenous Antibodies Sales (K Bottles) by Application (2020-2025)
 Table 61. Global Intravenous Antibodies Sales (K Bottles) by Application (2026-2031)
 Table 62. Global Intravenous Antibodies Sales Market Share by Application (2020-2025)
 Table 63. Global Intravenous Antibodies Sales Market Share by Application (2026-2031)
 Table 64. Global Intravenous Antibodies Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravenous Antibodies Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravenous Antibodies Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravenous Antibodies Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravenous Antibodies Price (US$/Bottle) by Application (2020-2025)
 Table 69. Global Intravenous Antibodies Price (US$/Bottle) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 73. Baxter Intravenous Antibodies Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 78. Grifols Intravenous Antibodies Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 83. CSL Intravenous Antibodies Product
 Table 84. CSL Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 88. Octapharma Intravenous Antibodies Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. Biotest Company Information
 Table 91. Biotest Description and Business Overview
 Table 92. Biotest Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 93. Biotest Intravenous Antibodies Product
 Table 94. Biotest Recent Developments/Updates
 Table 95. Kedrion Company Information
 Table 96. Kedrion Description and Business Overview
 Table 97. Kedrion Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 98. Kedrion Intravenous Antibodies Product
 Table 99. Kedrion Recent Developments/Updates
 Table 100. Hualan Bio Company Information
 Table 101. Hualan Bio Description and Business Overview
 Table 102. Hualan Bio Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 103. Hualan Bio Intravenous Antibodies Product
 Table 104. Hualan Bio Recent Developments/Updates
 Table 105. CNBG Company Information
 Table 106. CNBG Description and Business Overview
 Table 107. CNBG Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 108. CNBG Intravenous Antibodies Product
 Table 109. CNBG Recent Developments/Updates
 Table 110. Shanghai RAAS Company Information
 Table 111. Shanghai RAAS Description and Business Overview
 Table 112. Shanghai RAAS Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 113. Shanghai RAAS Intravenous Antibodies Product
 Table 114. Shanghai RAAS Recent Developments/Updates
 Table 115. CBPO Company Information
 Table 116. CBPO Description and Business Overview
 Table 117. CBPO Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 118. CBPO Intravenous Antibodies Product
 Table 119. CBPO Recent Developments/Updates
 Table 120. LFB Group Company Information
 Table 121. LFB Group Description and Business Overview
 Table 122. LFB Group Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 123. LFB Group Intravenous Antibodies Product
 Table 124. LFB Group Recent Developments/Updates
 Table 125. BPL Company Information
 Table 126. BPL Description and Business Overview
 Table 127. BPL Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 128. BPL Intravenous Antibodies Product
 Table 129. BPL Recent Developments/Updates
 Table 130. Sichuan Yuanda Shuyang Company Information
 Table 131. Sichuan Yuanda Shuyang Description and Business Overview
 Table 132. Sichuan Yuanda Shuyang Intravenous Antibodies Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 133. Sichuan Yuanda Shuyang Intravenous Antibodies Product
 Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Intravenous Antibodies Distributors List
 Table 138. Intravenous Antibodies Customers List
 Table 139. Intravenous Antibodies Market Trends
 Table 140. Intravenous Antibodies Market Drivers
 Table 141. Intravenous Antibodies Market Challenges
 Table 142. Intravenous Antibodies Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Antibodies
 Figure 2. Global Intravenous Antibodies Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravenous Antibodies Market Share by Type: 2024 & 2031
 Figure 4. IgG Product Picture
 Figure 5. IgA Product Picture
 Figure 6. IgM Product Picture
 Figure 7. IgE Product Picture
 Figure 8. IgD Product Picture
 Figure 9. Global Intravenous Antibodies Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Intravenous Antibodies Market Share by Application: 2024 & 2031
 Figure 11. Hospitals
 Figure 12. Clinics
 Figure 13. Others
 Figure 14. Global Intravenous Antibodies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Intravenous Antibodies Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Intravenous Antibodies Sales (2020-2031) & (K Bottles)
 Figure 17. Global Intravenous Antibodies Average Price (US$/Bottle) & (2020-2031)
 Figure 18. Intravenous Antibodies Report Years Considered
 Figure 19. Intravenous Antibodies Sales Share by Manufacturers in 2024
 Figure 20. Global Intravenous Antibodies Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Intravenous Antibodies Players: Market Share by Revenue in Intravenous Antibodies in 2024
 Figure 22. Intravenous Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Intravenous Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Intravenous Antibodies Sales Market Share by Country (2020-2031)
 Figure 25. North America Intravenous Antibodies Revenue Market Share by Country (2020-2031)
 Figure 26. United States Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Intravenous Antibodies Sales Market Share by Country (2020-2031)
 Figure 29. Europe Intravenous Antibodies Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Intravenous Antibodies Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Intravenous Antibodies Revenue Market Share by Region (2020-2031)
 Figure 37. China Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Intravenous Antibodies Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Intravenous Antibodies Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Intravenous Antibodies Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Intravenous Antibodies Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Intravenous Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Intravenous Antibodies by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Intravenous Antibodies by Type (2020-2031)
 Figure 58. Global Intravenous Antibodies Price (US$/Bottle) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Intravenous Antibodies by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Intravenous Antibodies by Application (2020-2031)
 Figure 61. Global Intravenous Antibodies Price (US$/Bottle) by Application (2020-2031)
 Figure 62. Intravenous Antibodies Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Intravenous Immunoglobulin IVIg Market Research Report 2025
Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immune Globulin Therapies Market Research Report 2024
IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030
Global Intravenous Injection Immunoglobulin Market Research Report 2024
Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immunoglobulin IVIg Therapy Market Research Report 2025
Global IVD Antibody Market Research Report 2025
Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024
Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulin Product Market Research Report 2024
Large Volume Intravenous Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulin Injection Market Research Report 2024
Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal derived Immune Globulin Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Hyperimmune Globulins Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions